Liyan Bai

489 total citations
30 papers, 365 citations indexed

About

Liyan Bai is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Liyan Bai has authored 30 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Liyan Bai's work include Liver physiology and pathology (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Liyan Bai is often cited by papers focused on Liver physiology and pathology (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Liyan Bai collaborates with scholars based in China, South Korea and Japan. Liyan Bai's co-authors include Myung Ho Jeong, Hae Jin Kee, Masayoshi Namba, Seung‐Jung Kee, Koichiro Mihara, Xinguo Wang, Wenyan Zhang, Hao Wu, Masamitsu Honma and Yoichi Kondo and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Cancer.

In The Last Decade

Liyan Bai

27 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyan Bai China 12 190 73 68 56 53 30 365
Weiqi Tan China 9 347 1.8× 86 1.2× 39 0.6× 65 1.2× 47 0.9× 12 488
Yue Shao China 12 145 0.8× 90 1.2× 104 1.5× 70 1.3× 21 0.4× 26 373
Yoichiro Takami Japan 13 178 0.9× 28 0.4× 33 0.5× 39 0.7× 18 0.3× 25 385
Antonina Kolmakova United States 12 199 1.0× 58 0.8× 46 0.7× 95 1.7× 30 0.6× 16 389
Weixue Tang China 13 278 1.5× 160 2.2× 90 1.3× 43 0.8× 14 0.3× 38 507
Haiyan Zhu China 9 243 1.3× 66 0.9× 47 0.7× 22 0.4× 18 0.3× 26 392
Zhang Lin China 10 142 0.7× 32 0.4× 43 0.6× 67 1.2× 22 0.4× 37 386
Feng Hong China 11 158 0.8× 70 1.0× 34 0.5× 38 0.7× 9 0.2× 24 301

Countries citing papers authored by Liyan Bai

Since Specialization
Citations

This map shows the geographic impact of Liyan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Bai more than expected).

Fields of papers citing papers by Liyan Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Bai. The network helps show where Liyan Bai may publish in the future.

Co-authorship network of co-authors of Liyan Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Bai. A scholar is included among the top collaborators of Liyan Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Bai. Liyan Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xiong, Jie, Liyan Bai, Bo Wang, et al.. (2025). Histone acetyltransferase 1 promotes postinfarction inflammatory response by regulation of monocyte histone succinylation. Nature Communications. 16(1). 11718–11718.
3.
Xiong, Jie, Liyan Bai, Bo Wang, et al.. (2025). β-Hydroxybutyrate Facilitates Homeostasis of Hypoxic Endothelial Cells After Myocardial Infarction via Histone Lysine β-Hydroxybutyrylation of CPT1A. JACC Basic to Translational Science. 10(5). 588–607. 3 indexed citations
4.
Huang, Chen, Menglan Zhang, Liyan Bai, et al.. (2024). Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review. Frontiers in Oncology. 14. 1453259–1453259. 2 indexed citations
5.
Bian, Linjie, Junyan Xu, Panli Li, Liyan Bai, & Shaoli Song. (2024). Comparison of 68Ga-DOTANOC and 18F-FDOPA PET/CT for Detection of Recurrent or Metastatic Paragangliomas. Radiology Imaging Cancer. 7(1). e240059–e240059. 1 indexed citations
6.
Bai, Liyan, Junyan Xu, Xiaoping Xu, et al.. (2024). The Application of <sup>68</sup>Ga-Somatostatin Analog and <sup>18</sup>F-FDG PET/CT for Bone Metastasis from Neuroendocrine Tumors. Neuroendocrinology. 114(8). 775–785. 1 indexed citations
7.
Hua, Cheng, et al.. (2024). 68Ga labeled Olmutinib: Design, synthesis, and evaluation of a novel PET EGFR probe. Bioorganic Chemistry. 153. 107987–107987. 1 indexed citations
8.
Sun, Simei, et al.. (2024). Beyond β-Blockade: ACE Inhibitors Reduce Non-Cardiac Mortality in High Killip Grade AMI Patients. Journal of Cardiovascular Pharmacology and Therapeutics. 29. 2234822689–2234822689.
9.
Bai, Liyan, Hae Jin Kee, Seong Hoon Kim, et al.. (2023). Protocatechuic acid prevents isoproterenol‐induced heart failure in mice by downregulating kynurenine‐3‐monooxygenase. Journal of Cellular and Molecular Medicine. 27(16). 2290–2307. 12 indexed citations
10.
Liu, Chunyan & Liyan Bai. (2023). Thermodynamic Modelling for the Prediction and Optimisation of Long-Term Performance in Wooden Structures. International Journal of Heat and Technology. 41(5). 1341–1348.
11.
Bai, Liyan, et al.. (2022). Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg. Journal of Cellular and Molecular Medicine. 26(14). 4076–4086. 18 indexed citations
12.
Bai, Liyan, Myung Ho Jeong, Joon Ho Ahn, et al.. (2021). Higher Long-Term Mortality in Patients with Non-ST-Elevation Myocardial Infarction than ST-Elevation Myocardial Infarction after Discharge. Yonsei Medical Journal. 62(5). 400–400. 12 indexed citations
13.
Jeong, Myung Ho, Liyan Bai, Joon Ho Ahn, et al.. (2021). Long-term clinical outcomes of type 1 vs. type 2 myocardial infarction in patients who underwent angiography: data from the Korea acute myocardial infarction-national institute of health registry. Cardiovascular Diagnosis and Therapy. 12(1). 55–66. 3 indexed citations
14.
Bai, Liyan, Hae Jin Kee, Sin Young Choi, et al.. (2020). HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model. Biomedicine & Pharmacotherapy. 134. 111162–111162. 18 indexed citations
15.
Kano, Yasuhiko, Miyuki Akutsu, Shin‐ichi Tsunoda, et al.. (2000). In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis. Leukemia. 14(3). 379–388. 27 indexed citations
16.
Bai, Liyan, et al.. (1998). Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-β- d -arabinofuranosyl-2-fluoroadenine. Journal of Cancer Research and Clinical Oncology. 124(7). 367–373. 11 indexed citations
17.
Miyazaki, Masahiro, Koichiro Mihara, Liyan Bai, et al.. (1993). Immortalization of Epithelial-like Cells from Human Liver Tissue with SV40 T-Antigen Gene. Experimental Cell Research. 206(1). 27–35. 21 indexed citations
18.
Bai, Liyan, Koichiro Mihara, Yoichi Kondo, Masamitsu Honma, & Masayoshi Namba. (1993). Immortalization of normal human fibroblasts by treatment with 4‐nitroquinoline 1‐oxide. International Journal of Cancer. 53(3). 451–456. 44 indexed citations
19.
Miyazaki, Masahiro, Liyan Bai, Hiroko Taga, et al.. (1991). Expression of liver-specific functions and secretion of a hepatocyte growth factor by a newly established rat hepatoma cell line growing in a chemically-defined serum-free medium. Research in Experimental Medicine. 191(1). 297–307. 4 indexed citations
20.
Bai, Liyan, et al.. (1990). Influence of liver tumor promoters and structurally related chemicals on survival of normal adult rat hepatocytes in primary culture. Journal of Cancer Research and Clinical Oncology. 116(3). 259–263. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiqi Tan Breakdown of academic impact, for papers by Yue Shao Breakdown of academic impact, for papers by Yoichiro Takami Breakdown of academic impact, for papers by Antonina Kolmakova Breakdown of academic impact, for papers by Weixue Tang Breakdown of academic impact, for papers by Haiyan Zhu Breakdown of academic impact, for papers by Zhang Lin Breakdown of academic impact, for papers by Feng Hong
Rankless by CCL
2026